These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 7945543)

  • 1. Serum and urine levels of levocarnitine family components in genetically diabetic rats.
    Morabito E; Corsico N; Marzo A; Arrigoni Martelli E
    Arzneimittelforschung; 1994 Aug; 44(8):965-8. PubMed ID: 7945543
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of acetyl-L-carnitine treatment on the levels of levocarnitine and its derivatives in streptozotocin-diabetic rats.
    Marzo A; Corsico N; Cardace G; Morabito E
    Arzneimittelforschung; 1993 Mar; 43(3):339-42. PubMed ID: 8489564
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Homeostatic equilibrium of L-carnitine family before and after i.v. administration of propionyl-L-carnitine in humans, dogs and rats.
    Marzo A; Cardace G; Corbelleta C; Bassani E; Morabito E; Arrigoni Martelli E
    Eur J Drug Metab Pharmacokinet; 1991; Spec No 3():357-63. PubMed ID: 1820908
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Assay of carnitine in plasma and urine of healthy adults].
    Niu YJ; Jiang ZM; Shu H; Li CF; Liu W; Yao GX; Jiang J; Li JQ; Longo A
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2002 Apr; 24(2):185-7. PubMed ID: 12905800
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urinary excretion of L-carnitine and its short-chain acetyl-L-carnitine in patients undergoing carboplatin treatment.
    Mancinelli A; D'Iddio S; Bisonni R; Graziano F; Lippe P; Calvani M
    Cancer Chemother Pharmacol; 2007 Jun; 60(1):19-26. PubMed ID: 16988826
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Short term effects of L-carnitine on serum lipids in STZ-induced diabetic rats.
    Eskandari HG; Cimen MY; Tamer L; Kanik A; Atik U
    Diabetes Res Clin Pract; 2004 Nov; 66(2):129-32. PubMed ID: 15533579
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determination of free L-carnitine levels in type II diabetic women with and without complications.
    Poorabbas A; Fallah F; Bagdadchi J; Mahdavi R; Aliasgarzadeh A; Asadi Y; Koushavar H; Vahed Jabbari M
    Eur J Clin Nutr; 2007 Jul; 61(7):892-5. PubMed ID: 17311064
    [TBL] [Abstract][Full Text] [Related]  

  • 8. L-carnitine treatment partially restores urinary bladder function of streptozotocin diabetic rats.
    Gur S; Irat AM
    Urol Int; 2008; 81(3):340-6. PubMed ID: 18931555
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disposition of L-carnitine and acetyl-L-carnitine in the isolated perfused rat kidney.
    Mancinelli A; Longo A; Shanahan K; Evans AM
    J Pharmacol Exp Ther; 1995 Sep; 274(3):1122-8. PubMed ID: 7562478
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of L-carnitine treatment on oxidant/antioxidant state and vascular reactivity of streptozotocin-diabetic rat aorta.
    Irat AM; Aktan F; Ozansoy G
    J Pharm Pharmacol; 2003 Oct; 55(10):1389-95. PubMed ID: 14607021
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of propionyl-L-carnitine in humans: evidence for saturable tubular reabsorption.
    Pace S; Longo A; Toon S; Rolan P; Evans AM
    Br J Clin Pharmacol; 2000 Nov; 50(5):441-8. PubMed ID: 11069438
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decreased tissue distribution of L-carnitine in juvenile visceral steatosis mice.
    Yokogawa K; Higashi Y; Tamai I; Nomura M; Hashimoto N; Nikaido H; Hayakawa J; Miyamoto K; Tsuji A
    J Pharmacol Exp Ther; 1999 Apr; 289(1):224-30. PubMed ID: 10087008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Morphometric and quantitative evaluation of the NADH-diaphorase positive myenteric neurons of the jejunum of streptozotocin-diabetic rats supplemented with acetyl-L-carnitine.
    De Miranda Neto MH; Defani MA; Fregonesi CE; Natali MR; Pereira A
    Anat Histol Embryol; 2005 Jun; 34(3):154-8. PubMed ID: 15929729
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Excretion and metabolism of propionyl-L-carnitine in the isolated perfused rat kidney.
    Evans AM; Mancinelli A; Longo A
    J Pharmacol Exp Ther; 1997 Jun; 281(3):1071-6. PubMed ID: 9190838
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Congenic diabetes-prone BB.Sa and BB.Xs rats differ from their progenitor strain BB/OK in frequency and severity of insulin-dependent diabetes mellitus.
    van den Brandt J; Kovács P; Klöting I
    Biochem Biophys Res Commun; 1999 Oct; 263(3):843-7. PubMed ID: 10512768
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polyol pathway hyperactivity is closely related to carnitine deficiency in the pathogenesis of diabetic neuropathy of streptozotocin-diabetic rats.
    Nakamura J; Koh N; Sakakibara F; Hamada Y; Hara T; Sasaki H; Chaya S; Komori T; Nakashima E; Naruse K; Kato K; Takeuchi N; Kasuya Y; Hotta N
    J Pharmacol Exp Ther; 1998 Dec; 287(3):897-902. PubMed ID: 9864270
    [TBL] [Abstract][Full Text] [Related]  

  • 17. L-carnitine treatment improves brain stem auditory evoked potentials in diabetic rats.
    Yildiz O; Ozata M; Ozkardeş A; Corakçi A; Gündoğan N; Gündoğan MA
    Neuroreport; 1996 Nov; 7(18):2957-9. PubMed ID: 9116218
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of propionyl-L-carnitine on motor nerve conduction, autonomic cardiac function, and nerve blood flow in rats with streptozotocin-induced diabetes: comparison with an aldose reductase inhibitor.
    Hotta N; Koh N; Sakakibara F; Nakamura J; Hamada Y; Wakao T; Hara T; Mori K; Naruse K; Nakashima E; Sakamoto N
    J Pharmacol Exp Ther; 1996 Jan; 276(1):49-55. PubMed ID: 8558455
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Morphoquantitative aspects of nitrergic myoenteric neurons from the stomach of diabetic rats supplemented with acetyl-L-carnitine.
    Fregonesi CE; Molinari SL; Alves AM; Defani MA; Zanoni JN; Bazotte RB; de Miranda Neto MH
    Anat Histol Embryol; 2005 Apr; 34(2):93-7. PubMed ID: 15771670
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vasopressin and urinary concentrating activity in diabetes mellitus.
    Ahloulay M; Schmitt F; Déchaux M; Bankir L
    Diabetes Metab; 1999 Sep; 25(3):213-22. PubMed ID: 10499190
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.